VGTI develops research and teaching programs to respond to infectious disease threats, including AIDS, chronic viral infection-associated diseases, newly emerging diseases, and infectious diseases of the elderly. Learn more
About us
The Vaccine and Gene Therapy Institute (VGTI) at Oregon Health & Science University (OHSU) has assembled a multidisciplinary team of scientists to respond to serious viral disease threats, including AIDS, chronic viral infection-associated diseases, newly emerging viral diseases and infectious diseases of the elderly. Our Programs are intended to span the continuum between basic and clinical science, in which discoveries are rapidly advanced from the level of molecular and cellular biology through animal models and ultimately into clinical testing. Learn more
Upcoming seminars
Thursday September 28th, 2017 9:30am - VGTI Seminar Room
Topic: HCMV miR-US22 Down-regulation of Egr-1 is Necessary for Viral Reactivation in CD34+ HPC
Speaker: Iliyana Mikel, PhD
Post-Doctoral Scholar, VGTI
Oregon Health and Science University
Recent publications
PLOS, March 9, 2017
Zika Virus infection of rhesus macaques leads to viral persistence in multiple
tissues
Journal of Virology, February 1, 2017
A microRNA screen identifies the Wnt signaling pathway as a regulator of the interferon response during flavivirus infection
American Society for Cell Biology, January 1, 2017
p120-catenin regulates VE-cadherin endocytosis and degradation induced by the Kaposi sarcoma-associated ubiquitin ligase K5
PLOS, December 15, 2016
Peptide Processing Is Critical for T-Cell Memory Inflation and May Be Optimized to Improve Immune Protection by CMV-Based Vaccine Vectors
PLOS, December 7, 2016
Microbial Translocation and Inflammation Occur in Hyperacute Immunodeficiency Virus Infection and Compromise Host Control of Virus Replication
The Journal of Infectious Diseases, December 5, 2016
Animal Models of Chikungunya Virus Infection and Disease